Biogen Inc (NASDAQ: BIIB)
DRUGS - BiotechnologySector: Health Care
Stock price data as of 04/22/2022
Closing price: 209.99
Support price level: | $204.23 |
Resistance price level: | $219.86 |
Relative strength index (14-day RSI) | 49.3 |
Beta | 0.61 |
- Volatility is forecast to rise over the next month.
- BIIB is below its 200-day moving average - additional caution warranted in long positions.
Low | High | Price as % of Range |
$193.77 | $414.71 | 10.6% |
200 day | 50 day | 20 day | 10 day |
$261.72 | $209.81 | $212.74 | $214.43 |
Historical (5 year) |
Last month | Current estimate | Next month forecast |
44.2% | 37.8% | 40.1% | 47.4% |
- 10.9% in the next week.
- 26.8% in the next month.
- 105.2% in the next year.
Company news for Biogen Inc
Google Finance |
MarketWatch |
WSJ
Analysis for other Health Care stocks